Natco Pharma Limited — Investor Meet, 03-02-2025: Analysts/Institutional Investor Meet/Con. Call Updates

NATCO Pharma has scheduled an earnings call to discuss its financial performance for the quarter ended 31st December 2024. The call is set for 11:00 AM IST on 13th February 2025 and will feature insights from key executives, including the Vice Chairman & CEO, Mr. Rajeev Nannapaneni, and the Executive Vice President – Crop Health Sciences, Mr. Rajesh Chebiyam.

Investors can expect discussions on key financial metrics and trends, as well as strategic insights related to market dynamics and upcoming initiatives. The format will allow for a Q&A session where analysts can seek clarifications about revenue performance, margins, and operational strategies. This setting provides a vital opportunity for stakeholders to gauge the company's direction and market positioning in the competitive landscape.